DOI:
10.1055/s-00000099
Zeitschrift für Orthopädie und Unfallchirurgie
LinksClose Window
References
Tap WD, Jones RL, Van Tine BA. et al.
Olaratumab and doxorubicin versus doxorubicin alone for treatment of soft-tissue sarcoma: an open-label phase 1b and randomised phase 2 trial.
Lancet 2016;
388: 488-497
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.